A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
News|Slideshows|December 2, 2021
NIH Influenza and COVID-19 Guideline Topline: Testing, Treatment, and Vaccination
Author(s)Grace Halsey
The influenza and SARS-CoV-2 viruses once again are in cocirculation. Following is a topline look at the NIH guideline on their simultaneous management.
Advertisement
The National Institutes of Health has published
This section of the guideline includes:
- Clinical presentation similarities/differences between the 2 viruses
- Potential for coinfection with
influenza and SARS-CoV-2 - Testing for influenza and SARS-CoV-2 in patients with acute respiratory symptoms
- Treatment of influenza in the setting of cocirculatling SARS-CoV-2
Following is a topline summary of the guideline in a short slide show.
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
3
FAQ: What the Endocrine Society’s New Scientific Statement Means for Obesity Treatment
4
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
5